Medmira Inc. Stock
Your prediction
Medmira Inc. Stock
A very strong showing by Medmira Inc. today, with an increase of €0.003 (6.670%) compared to yesterday's price.
Pros and Cons of Medmira Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medmira Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medmira Inc. | 6.670% | 14.286% | 5.263% | -12.088% | -50.000% | 9.589% | - |
| Theralase Technologies Inc | -1.740% | -1.744% | -21.028% | -46.519% | -47.188% | -61.591% | -34.496% |
| Atossa Genetics Inc | 6.560% | 12.610% | 8.782% | -29.799% | -20.497% | 21.021% | 7.023% |
| Aortech International plc | -0.990% | 2.564% | -1.961% | 3.627% | -10.714% | -79.757% | -94.318% |
News
Health Canada approves MedMira’s Reveal® Rapid TP Test - Urgent New Tool In The Battle Against Syphilis
Halifax, Nova Scotia, 26 August 2025 – MedMira Inc. (MedMira) (TSXV: MIR) announced today that it has received approval from Health Canada for its Reveal® TP (Syphilis) Antibody Test (Reveal®
MedMira Announces Launch of Clinical Trial for Its Multiplo® TP/HIV Self-Test in Canada
Halifax, Nova Scotia, July 7, 2025 – MedMira Inc. (MedMira) (TSXV: MIR) and REACH Nexus are excited to announce a clinical trial has officially started earlier than anticipated to evaluate